Second Asian Consensus Report on Functional Dyspepsia
Revision of the 2024 National Consensus on the Management of Diarrhea in Adults in Indonesia
Diarrhea is a common complaint encountered by patients in daily practice. According to the 2016 Global Burden of Disease study, diarrhea is among the top 10 diseases with a significant impact on patients. Although various efforts to prevent diarrhea …
Indonesia Inflammatory Bowel Disease (IBD) Masterclass 2024
The ever-growing knowledge about Inflammatory Bowel Disease (IBD), along with the latest data on the use of biological agents, pre-administration preparations such as vaccination and infection panel screening, as well as the use of immunomodulators, prompted the Central Board of …
The Second Plenary Meeting of the Central Board of the Indonesian Gastroenterology Association (PB PGI)
Based on the results of the first plenary meeting of PGI, held on January 20, 2024, at the Shangri-La Hotel, Jakarta, it was decided that in the next four months, each commission is expected to report on the progress …
Inauguration of the Central Board of the Indonesian Gastroenterology Association (PB PGI) for the 2023–2026 Term
The Central Board of the Indonesian Gastroenterology Association (PB PGI) for the 2023–2026 term officially conducted the inauguration of its new management. This inauguration was held in conjunction with the Indonesian Liver Researchers Association (PB PPHI) and the Indonesian …
Expert Meeting of Chronic Constipation: Exploring the Latest Updates on Chronic Constipation in Special Populations in Indonesia
In recent decades, the incidence of chronic constipation has been on the rise and is increasingly encountered in daily practice, requiring heightened awareness among medical practitioners across Indonesia, particularly in gastroenterology and gastrointestinal endoscopy. In response, the Central Board of …
Addendum to the National Consensus on the Management of Dyspepsia and Helicobacter Pylori Infection in Indonesia 2024
Based on the latest scientific data, there is a new pharmacological therapy available in Indonesia for the management of Helicobacter pylori infection: Vonoprazan. Vonoprazan is a novel Potassium-Competitive Acid Blocker (P-CAB) that can replace the role of Proton …
Masterclass Inflammatory Bowel Disease (IBD): Meet and Practice from the Expert
The Central Board of the Indonesian Gastroenterology Association (PB PGI) held the “Masterclass Inflammatory Bowel Disease (IBD): Meet and Practice from the Expert” on February 4, 2024, at the Double Tree Hotel, Jakarta.
This event brought together 22 gastroenterology …
First Plenary Meeting of the Indonesian Gastroenterology Association (PB PGI)
Adendum Konsensus Nasional Penatalaksanaan Konstipasi di Indonesia Tahun 2023
Currently, there is a new pharmacological modality for chronic constipation available in Indonesia: Elobixibat. Elobixibat is a bile acid transporter inhibitor that works by inhibiting the reabsorption of bile salts in enterocytes in the ileum, so that the residual …
